182 related articles for article (PubMed ID: 37949879)
1. PRMT2 promotes HIV-1 latency by preventing nucleolar exit and phase separation of Tat into the Super Elongation Complex.
Jin J; Bai H; Yan H; Deng T; Li T; Xiao R; Fan L; Bai X; Ning H; Liu Z; Zhang K; Wu X; Liang K; Ma P; Gao X; Hu D
Nat Commun; 2023 Nov; 14(1):7274. PubMed ID: 37949879
[TBL] [Abstract][Full Text] [Related]
2. Fused in sarcoma silences HIV gene transcription and maintains viral latency through suppressing AFF4 gene activation.
Krasnopolsky S; Marom L; Victor RA; Kuzmina A; Schwartz JC; Fujinaga K; Taube R
Retrovirology; 2019 Jun; 16(1):16. PubMed ID: 31238957
[TBL] [Abstract][Full Text] [Related]
3. UHRF1 Suppresses HIV-1 Transcription and Promotes HIV-1 Latency by Competing with p-TEFb for Ubiquitination-Proteasomal Degradation of Tat.
Liang T; Zhang Q; Wu Z; Chen P; Huang Y; Liu S; Li L
mBio; 2021 Aug; 12(4):e0162521. PubMed ID: 34465029
[TBL] [Abstract][Full Text] [Related]
4. Super elongation complex promotes early HIV transcription and its function is modulated by P-TEFb.
Kuzmina A; Krasnopolsky S; Taube R
Transcription; 2017 May; 8(3):133-149. PubMed ID: 28340332
[TBL] [Abstract][Full Text] [Related]
5. The KAT5-Acetyl-Histone4-Brd4 axis silences HIV-1 transcription and promotes viral latency.
Li Z; Mbonye U; Feng Z; Wang X; Gao X; Karn J; Zhou Q
PLoS Pathog; 2018 Apr; 14(4):e1007012. PubMed ID: 29684085
[TBL] [Abstract][Full Text] [Related]
6. Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription.
Mousseau G; Valente ST
Curr Pharm Des; 2017; 23(28):4079-4090. PubMed ID: 28641539
[TBL] [Abstract][Full Text] [Related]
7. The BET bromodomain inhibitor JQ1 activates HIV latency through antagonizing Brd4 inhibition of Tat-transactivation.
Li Z; Guo J; Wu Y; Zhou Q
Nucleic Acids Res; 2013 Jan; 41(1):277-87. PubMed ID: 23087374
[TBL] [Abstract][Full Text] [Related]
8. The Molecular Basis for Human Immunodeficiency Virus Latency.
Mbonye U; Karn J
Annu Rev Virol; 2017 Sep; 4(1):261-285. PubMed ID: 28715973
[TBL] [Abstract][Full Text] [Related]
9. The protein arginine methyltransferase PRMT6 inhibits HIV-1 Tat nucleolar retention.
Fulcher AJ; Sivakumaran H; Jin H; Rawle DJ; Harrich D; Jans DA
Biochim Biophys Acta; 2016 Feb; 1863(2):254-62. PubMed ID: 26611710
[TBL] [Abstract][Full Text] [Related]
10. Insights into HIV-1 proviral transcription from integrative structure and dynamics of the Tat:AFF4:P-TEFb:TAR complex.
Schulze-Gahmen U; Echeverria I; Stjepanovic G; Bai Y; Lu H; Schneidman-Duhovny D; Doudna JA; Zhou Q; Sali A; Hurley JH
Elife; 2016 Oct; 5():. PubMed ID: 27731797
[TBL] [Abstract][Full Text] [Related]
11. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
Macías D; Oya R; Saniger L; Martín F; Luque F
Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
[TBL] [Abstract][Full Text] [Related]
12. A Stronger Transcription Regulatory Circuit of HIV-1C Drives the Rapid Establishment of Latency with Implications for the Direct Involvement of Tat.
Chakraborty S; Kabi M; Ranga U
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669338
[TBL] [Abstract][Full Text] [Related]
13. BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.
Boehm D; Calvanese V; Dar RD; Xing S; Schroeder S; Martins L; Aull K; Li PC; Planelles V; Bradner JE; Zhou MM; Siliciano RF; Weinberger L; Verdin E; Ott M
Cell Cycle; 2013 Feb; 12(3):452-62. PubMed ID: 23255218
[TBL] [Abstract][Full Text] [Related]
14. Nucleolar protein NOP2/NSUN1 suppresses HIV-1 transcription and promotes viral latency by competing with Tat for TAR binding and methylation.
Kong W; Biswas A; Zhou D; Fiches G; Fujinaga K; Santoso N; Zhu J
PLoS Pathog; 2020 Mar; 16(3):e1008430. PubMed ID: 32176734
[TBL] [Abstract][Full Text] [Related]
15. The Tat/P-TEFb Protein-Protein Interaction Determining Transcriptional Activation of HIV.
Asamitsu K; Okamoto T
Curr Pharm Des; 2017; 23(28):4091-4097. PubMed ID: 28699519
[TBL] [Abstract][Full Text] [Related]
16. A truncated HIV Tat demonstrates potent and specific latency reversal activity.
Van Gulck E; Pardons M; Nijs E; Verheyen N; Dockx K; Van Den Eynde C; Battivelli E; Vega J; Florence E; Autran B; Archin NM; Margolis DM; Katlama C; Hamimi C; Van Den Wyngaert I; Eyassu F; Vandekerckhove L; Boden D
Antimicrob Agents Chemother; 2023 Nov; 67(11):e0041723. PubMed ID: 37874295
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 latency in actively dividing human T cell lines.
Jeeninga RE; Westerhout EM; van Gerven ML; Berkhout B
Retrovirology; 2008 Apr; 5():37. PubMed ID: 18439275
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for ELL2 and AFF4 activation of HIV-1 proviral transcription.
Qi S; Li Z; Schulze-Gahmen U; Stjepanovic G; Zhou Q; Hurley JH
Nat Commun; 2017 Jan; 8():14076. PubMed ID: 28134250
[TBL] [Abstract][Full Text] [Related]
19. HIV latency reversing agents act through Tat post translational modifications.
Khoury G; Mota TM; Li S; Tumpach C; Lee MY; Jacobson J; Harty L; Anderson JL; Lewin SR; Purcell DFJ
Retrovirology; 2018 May; 15(1):36. PubMed ID: 29751762
[TBL] [Abstract][Full Text] [Related]
20. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
